T1	Limited_variation 14 24	RB1 status 
T2	Gene_or_protein 14 17	RB1 
T3	Pharmacodynamic_phenotype 100 109;40 51	cisplatin sensitivity 
T4	Chemical 100 109	cisplatin 
T5	Chemical 121 135	5-fluorouracil 
T6	Chemical 138 148	idarubicin 
T7	Chemical 151 161	epirubicin 
T8	Chemical 164 171	PRIMA-1 
T9	Chemical 182 193	fludarabine 
T10	Chemical 198 208	PD-0332991 
T11	Disease 243 247	TNBC 
T12	Chemical 112 116	CDDP
T13	Disease 55 59	TNBC
T14	Pharmacodynamic_phenotype 121 135;40 51;66 68	5-fluorouracil sensitivity to
T15	Pharmacodynamic_phenotype 138 148;40 51;66 68	idarubicin sensitivity to
T16	Pharmacodynamic_phenotype 151 161;40 51;66 68	epirubicin sensitivity to
T17	Pharmacodynamic_phenotype 164 171;40 51;66 68	PRIMA-1 sensitivity to
T18	Pharmacodynamic_phenotype 182 193;40 51;66 68	fludarabine sensitivity to
T19	Pharmacodynamic_phenotype 198 208;40 51;66 68	PD-0332991 sensitivity to
T20	Chemical 69 89	multiple other drugs
T21	Pharmacodynamic_phenotype 40 51;66 89	sensitivity to multiple other drugs
R1	isEquivalentTo Arg1:T12 Arg2:T4	
R2	influences Arg1:T1 Arg2:T17	
R3	influences Arg1:T1 Arg2:T16	
R4	influences Arg1:T1 Arg2:T15	
R5	influences Arg1:T1 Arg2:T14	
R6	influences Arg1:T1 Arg2:T18	
R7	influences Arg1:T1 Arg2:T3	
R8	influences Arg1:T1 Arg2:T19	
R9	influences Arg1:T1 Arg2:T21	
#1	AnnotatorNotes R7	neg
#2	AnnotatorNotes R5	neg
#3	AnnotatorNotes R4	neg
#4	AnnotatorNotes R3	neg
#5	AnnotatorNotes R2	neg
#6	AnnotatorNotes R6	neg
#7	AnnotatorNotes R8	neg
#8	AnnotatorNotes R9	neg
